# Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

> **NCT03918408** · PHASE1 · RECRUITING · sponsor: **Pacific Clear Vision Institute** · enrollment: 300 (estimated)

## Conditions studied

- Keratoconus, Unstable
- Bacterial Keratitis
- Ectasia of Cornea

## Interventions

- **COMBINATION_PRODUCT:** PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution

## Key facts

- **NCT ID:** NCT03918408
- **Lead sponsor:** Pacific Clear Vision Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-01
- **Primary completion:** 2029-12
- **Final completion:** 2030-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03918408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03918408, "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03918408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*